Recent Advances in Biosensors for Detecting Cancer-Derived Exosomes
Nan Cheng,Dan Du,Xinxian Wang,Dong Liu,Wentao Xu,Yunbo Luo,Yuehe Lin
DOI: https://doi.org/10.1016/j.tibtech.2019.04.008
2019-01-01
Trends in Biotechnology
Abstract:Exosomes are ideal candidates for reliable next-generation biomarkers for use in noninvasive methodologies for the early diagnosis and therapeutic response evaluation of cancer. With the development of biosensors for the detection of exosomes, individuals in resource-limited regions who previously had no access to advanced diagnostic tools can benefit and cancer therapy can also be improved, creating a promising trend for POC usage. The most recent advances in biosensors used to detect cancer-derived exosomes have focused on target choice, biological recognition strategies, and signal transduction techniques. Although various biosensors have been reported and summarized for the detection of cancer-derived exosomes, the challenges and some of the crucial issues in this field still need to be addressed before their use in clinical applications. Early detection and effective treatments are two of the greatest challenges in the fight against cancer. Cancer-derived exosomes are attractive biomarkers for the early diagnosis and therapeutic response evaluation of cancer. Here, we review recent advances in biosensors for the detection of cancer-derived exosomes. We discuss the potential exosomal biomarkers of various cancers, which can be applied as indicative targets in the design of biosensors. We further describe the fabrication of exosome detection biosensors with respect to biological recognition strategies and signal transduction techniques, which involve integrated scientific and technological aspects of analytical chemistry and nanotechnology. Furthermore, future research directions and challenges in using cancer-derived exosomes for point-of-care (POC) testing are presented. Early detection and effective treatments are two of the greatest challenges in the fight against cancer. Cancer-derived exosomes are attractive biomarkers for the early diagnosis and therapeutic response evaluation of cancer. Here, we review recent advances in biosensors for the detection of cancer-derived exosomes. We discuss the potential exosomal biomarkers of various cancers, which can be applied as indicative targets in the design of biosensors. We further describe the fabrication of exosome detection biosensors with respect to biological recognition strategies and signal transduction techniques, which involve integrated scientific and technological aspects of analytical chemistry and nanotechnology. Furthermore, future research directions and challenges in using cancer-derived exosomes for point-of-care (POC) testing are presented. mediated molecules involved in the development of adhesion bonds, which play a main role in several pathologies such as cancer and inflammatory diseases. large Y-shaped proteins that are typically produced by mammalian immune systems or phage display technology and used to identify invading organisms or substances. short oligonucleotides with 30–40 nucleobases that are synthesized in vitro without the need for animal or cell cultures and have the ability to bind specific analytes. core part of biosensors due to their role in recognizing the targets of interest using biological molecules. analytical devices that incorporate a biological material, a biologically derived material, or a biomimic that is intimately associated with or integrated within a physicochemical transducer or transducing microsystem. indicators of a biological state or condition in biological fluids, such as blood and urine, which can be a protein, a protein fragment, DNA/RNA, or an organic chemical produced by cancer cells. detecting cancers at their earliest stages is necessary for improving the survival rate of cancer patients. a paper-based device consisting of four components: a sample pad, a conjugate pad, a nitrocellulose membrane-containing test and control lines, and an absorbent pad. the lowest concentration of a target that can be detected at a specified level of confidence. short chains of approximately 50 or fewer amino acid monomers linked by peptide (amide) bonds, which are distinguished from proteins on the basis of their small size. patient care in the emergency room, in primary clinics, at home, or in other nonhospital settings, where diagnoses can be made and treatment regimens can be considered. enzymes that help proteolysis, which localize on the exosome surface secreted by various cell types. core part of biosensors function as physicochemical transducers or transducing microsystems, which can be optical, electrochemical, thermometric, magnetic, or micromechanical in nature. a surface-sensitive technique that enhances Raman scattering by molecules adsorbed on rough metal surfaces or by nanostructures. a label-free, real-time technique that allows molecular interactions occurring on the top of a gold layer to be detected based on monitoring changes in the refractive index. a family of four-transmembrane proteins, which could make a major contribution in exosomal message transfer and selective target binding. integrins mediating cell–cell or cell–extracellular matrix adhesion, such as integrins β1 and β2.